Literature DB >> 894516

Tissue binding of drugs.

M Gibaldi, P J McNamara.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 894516     DOI： 10.1002/jps.2600660846

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  11 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Pulmonary disease and drug kinetics.

Authors:  P du Souich; A J McLean; D Lalka; S Erill; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

4.  Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.

Authors:  E M Faed
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Pharmacokinetics and pharmacodynamics of warfarin at steady state.

Authors:  P A Routledge; P H Chapman; D M Davies; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

6.  Apparent volumes of distribution and drug binding to plasma proteins and tissues.

Authors:  M Gibaldi; P J McNamara
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

7.  Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.

Authors:  D Trenk; F Wagner; W Sachs; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.

Authors:  A Somogyi; M Albrecht; G Kliems; K Schäfer; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

9.  Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

10.  Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment.

Authors:  F Schlicht; C Staiger; J de Vries; U Gundert-Remy; R Hildebrandt; J Harenberg; N S Wang; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.